Abstract-The type II, class A macrophage scavenger receptor (SR-A) plays an important role in the pathogenesis of atherosclerosis and foam cell formation. However, its role in nonmacrophage cell lines remains unknown. To test the hypothesis that SR-A activity leads to proatherogenic changes in nonmacrophage cell lines, we generated Moloney murine leukemia virus-and vesicular stomatitis virus G protein-pseudotyped retroviruses containing SR-A type II cDNA, which were used for stable transfection of SR-A activity into mouse fibroblasts and rabbit aortic smooth muscle cells (SMCs). ␤-Galactosidase-transfected cell lines were used as controls. Transfected cell lines expressed functional SR-A mRNA and protein. Expression of SR-A activity was stable for at least 9 months. By electron microscopy, transfected receptors were located in coated pits and in intracellular structures resembling endocytotic vesicles. Expression of SR-A on the cell surface was verified by flow cytometry and by uptake and degradation of 125 I-labeled acetylated low density lipoprotein (LDL). Increases of 5-to 25-fold and of 6-to 8-fold in the rate of acetylated LDL degradation were observed in transfected fibroblasts and SMCs, respectively, compared with ␤-galactosidasetransfected control cell lines. Incubation of the transfected SMCs and fibroblasts with acetylated or oxidized LDL led to foam cell formation. Incubation with oxidized LDL also led to increased apoptosis and cell death. An altered morphology with increased cell size and granularity was observed in the most active SR-A SMC clones. It is concluded that stable overexpression of SR-A leads to foam cell formation and other proatherogenic changes in nonmacrophage cell lines. Stable SMC and fibroblast cell lines can be used as models for foam cell formation. The results also suggest that increased SR activity may play an important role in SMC-related pathology in atherosclerotic arteries. 
T he class A macrophage scavenger receptor (SR-A) belongs to a family of receptors that mediate the uptake of several negatively charged macromolecules, such as oxidized (ox) LDL. [1] [2] [3] [4] SR-A also participates in cell adhesion and defense against microorganisms. 5 In atherogenesis, SR-Amediated uptake of oxLDL plays an important role in the formation of lipid-filled macrophages. 3, 6, 7 Expression of SR-A in macrophages in human, rabbit, and mouse atherosclerotic lesions has been demonstrated, 6 -10 and SR-Aknockout mice develop less atherosclerosis than do their littermates. 11 SR-A expression is also induced Ͼ100-fold in macrophages in developing atherosclerotic lesions. 12 Although the importance of SR-A activity in macrophages has been clearly established, the role of SR-A in nonmacrophage cell lines remains unclear. Although cultured rabbit fibroblasts and smooth muscle cells (SMCs) express SR-A activity on stimulation with phorbol esters, 13 no or very limited SR-A expression has been detected in SMCs in human, Watanabe heritable hyperlipidemic rabbit, or cholesterol-fed New Zealand White rabbit atherosclerotic lesions. 6, 8, 9 Also, SR-A expression in atherosclerotic lesions of apoE3-Leiden transgenic mice has been detected in macrophages but not in SMCs. 10 However, in cholesterol-fed New Zealand White rabbits, in which the arterial wall was damaged by balloon denudation, SR-A immunoreactivity was detected in a small number of proliferating, intimal SMCs. 14, 15 Whether expression of the SR-A in SMCs and fibroblasts in vivo leads to foam cell formation and other proatherogenic changes remains unknown.
Retrovirus-mediated gene transfer can be used for stable transfection of eukaryotic cell lines in which gene expression is driven by a retroviral long-terminal repeat (LTR) promot-er. 16 Cell lines transfected by retroviral techniques have proved valuable for the analysis of transgene functions because they can lead to long-lasting, high-level expression of the transgene that is not regulated by natural promoters. Retroviruses also open up possibilities for in vivo gene transfer with prolonged transgene expression in target tissues. 16 The aim of the study was to test the hypothesis that SR-A activity leads to proatherogenic changes in nonmacrophage cell lines. It was found that SR-A expression leads to foam cell formation, enhanced cell death, and apoptosis in stably transfected SMCs and fibroblasts.
Methods

Virus Vectors and Cell Cultures
Retroviral vector ( Figure 1 ) was constructed from a parental vector pLRNL (where LϭLTR, RϭRous sarcoma virus promoter, Nϭneomycin, and LϭLTR) 17 by insertion of a bovine SR-A type II cDNA. 1, 2 in sense (pLSRNL) and antisense (pLS r RNL) orientation under control of the Moloney murine leukemia virus (MMLV) LTR. The internal neomycin-resistance gene is controlled by an RSV promoter. Plasmid sequences were verified by automated sequencing (A.L.F DNA sequencer, Pharmacia). Two C-deletion mutations occurred in the noncoding region of pLSRNL. Retrovirus vector containing Escherichia coli ␤-galactosidase (LacZ) cDNA 18 (pLZRNL) was used as a control. 19 2 and PA317 mouse fibroblast cell lines, 20, 21 rat fibroblast cell line F209, 17 human embryonal kidney 293GP cell line, 22 and rabbit aortic SMC line RAASMC (established in our laboratory from a newborn New Zealand White rabbit aortic explant 19 ) were used in the study. Cells were verified as SMCs by ␣-actin immunostaining. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco) at 37°C in a 5% CO 2 atmosphere. The growth medium was supplemented with 10% FCS, 100 U/mL penicillin, 100 g/mL streptomycin, and 2 mmol/L L-glutamine (Gibco). Neomycin-resistant cells were maintained in the same medium containing neomycin analogue G418 (400 g/mL, Sigma). Peritoneal macrophages were harvested from the peritoneal cavity of 8-week-old male mice. 23 Macrophages were cultured in RPMI containing 10% FBS and used for the experiments within 36 hours after isolation.
Production of Retroviruses and Stable Cell Lines
MMLV Retroviruses
For MMLV retroviruses, the ecotropic packaging cell line 2 20 was transfected with retroviral plasmids by using a standard calcium phosphate precipitation method. Viruses were harvested from 2 cells after 48 hours and used for infection of amphotropic PA317 packaging cells 21 as follows. On day 0, PA317 cells were plated at 5ϫ10 5 cells/10-cm dish. On day 1, monolayers were incubated for 16 hours with filtered (0.45 m) 2 supernatants in the presence of 8 g/mL Polybrene (Sigma). On day 2, the medium was replaced with G418-containing medium. After 10 to 12 days of selection, G418-resistant clones were isolated and expanded. 19 
Pseudotyped Retroviruses
Pseudotyped retroviral vector pLSRNL containing the G glycoprotein of vesicular stomatitis virus (VSV-G) was produced in human kidney 293GP cells cotransfected with MMLV gag and pol genes. 24 293GP cells were transfected by using a standard calcium phosphate coprecipitation with 50 g of pLSRNL DNA. Stable clones expressing SR-A were selected by using 600 g/mL geneticin. A stable producer clone was selected for the production of pseudotyped pLSRNL virus. To generate pseudotyped virus, the producer clone was transfected with pHCMV-G expression plasmid as described. 24 Fresh medium containing 10% FBS was changed after 8 to 12 hours of transfection. Pseudotyped viruses generated from the transfected cells were collected 24, 48, and 72 hours after the change of medium. Collected supernatants were filtered (0.45 m) and subjected to ultracentrifugation in a Beckman SW-28 rotor at 50 000g (25 000 rpm) at 4°C for 120 minutes. The pellets were resuspended overnight at 4°C in 200 L of 0.1ϫ Hanks'/1% sucrose in PBS and combined before titration and storage. 25 The concentrated viruses containing either SR-A or LacZ were used to transduce RAASMCs. A multiplicity of infection of 10 to 100 viruses was used to transduce RAASMCs in the presence of 8 g/mL Polybrene for 16 hours. After 48 hours the cells were trypsinized, and selection was started with 600 g/mL geneticin. After 10 to 12 days of selection, G418-resistant SMC clones were isolated and expanded. 19 
Determination of Virus Titers
MMLV-and VSV-G-pseudotyped viruses were titrated on F209 cells in the presence of Polybrene (8 g/mL). 19 Titers of the best MMLV producer clones for pLSRNL, pLS r RNL, and pLZRNL were 7ϫ10 4 , 2ϫ10 3 , and 8ϫ10 4 colony-forming units (cfu)/mL, respectively. Titers of the unconcentrated, pseudotyped viruses pLSRNL and pLZRNL were 10 4 to 10 6 cfu/mL. After concentration the titers were 10 6 to 10 7 cfu/mL.
Northern and Southern Blot Analyses
Poly(A)ϩ mRNA was isolated from the clones by an SDS/proteinase K method and used for Northern blot analysis. 26 Hybridizations were carried out overnight at 42°C with 10 6 counts per minute per milliliter of random-primed 32 P-labeled bovine SR-A probe, neomycin probe, or ␤-actin probe. 26 Genomic DNA was isolated from stably transfected clones and from untransduced control cells by proteinase K treatment for Southern blot analysis. 27 Genomic DNA (30 g) was digested with SduI, BspTI, and Mva1269I restriction enzymes (Fermantas, Finnzymes), and the fragments were separated in 0.8% agarose gel, blotted onto a nylon membrane, and hybridized with the SR-A probe. Autoradiography was used for signal detection.
Immunostaining
Cells were plated on glass chamber slides and were grown in 10% lipid-deficient serum/DMEM. Cells were fixed with 4% paraformaldehyde for 10 minutes at 20°C, permeabilized in 0.2% Triton X-100/PBS for 10 minutes, and washed with PBS. Thereafter, the cells were blocked in 3% BSA/PBS for 2 hours and incubated with SRKO 4 antibody 15 for 1 hour and subsequent incubation with biotinylated horse anti-mouse IgG (Vector Laboratories) for an additional 30 minutes. An avidin-biotin-horseradish peroxidase system (Vector Laboratories) was used for immunostaining. The nuclei were stained with hematoxylin. Cells incubated without the primary antibody were used as controls.
Immunoelectron Microscopy
To observe the localization of SR-A and SR-A-mediated endocytosis by immunoelectron microscopy, cell samples of untransduced and transduced PA317 fibroblasts were incubated for 48 hours in the presence of acetylated (ac) LDL (5 g/mL) and fixed for 10 minutes with 0.05% glutaraldehyde in 0.165 mol/L cacodylate buffer, pH 7.4. Immunostaining was carried out for 1 hour with an anti-bovine SR-A IgG-D2. 28 The samples were then incubated for 1 hour with an anti-mouse immunoglobulin [F(abЈ) 2 ] conjugated with peroxidase (Amersham). Between each staining step, washing with PBS containing 0.005% saponin (Sigma) was performed as previously described 29 to facilitate permeabilization of the cells. Peroxidase activity was visualized with 3,3Ј-diaminobenzidine as a substrate. After diaminobenzidine staining, the cells were postfixed with 1% OsO 4 for 60 minutes, dehydrated through a graded series of ethanols, embedded in Epon 812, and sectioned serially. Ultrathin sections were observed with an H-7500 electron microscope (Hitachi) without counterstaining.
Analysis of Lipoprotein Metabolism
Fluorescence Microscopy and Flow Cytometry Analysis to Measure DiI-acLDL Uptake LDL (dϭ1.019 to 1.063 g/mL) from fresh, human plasma was isolated by ultracentrifugation as described. 30 LDL was labeled with fluorescent DiI (1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate; Molecular Probes) as described 31 and then acetylated. For competition studies, LDL was acetylated with acetic anhydride 32 and oxidized by overnight incubation with copper ions (20 mol/L). 23 For the uptake assay of fluorescent lipoproteins, cells were incubated at 37°C on chamber slides with growth medium containing 10 g/mL DiI-acLDL for 4 to 8 hours in the presence or absence of acLDL, oxLDL, or polyinosinic acid (Sigma). Cells were either analyzed by flow cytometry or fixed with 0.05% glutaraldehyde or 4% paraformaldehyde (10 minutes, 20°C) for fluorescence microscopy. 33 For flow cytometry analysis, untransduced cells and stably transduced clones were grown in 10% FBS/DMEM and trypsinized 2 days before the assay. In some experiments, cells were stimulated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA) for 24 hours. Cultured fibroblasts or SMCs (1 to 2ϫ10 6 cells) were washed with PBS and incubated with 10 g/mL DiI-acLDL in 10% lipid-deficient serum/DMEM at 37°C for 5 hours. For competition assays, a 25-fold excess of acLDL, oxLDL, and polyinosinic acid was used. Immediately after the incubations, the cells were placed on ice and washed twice with ice-cold PBS. Cells were harvested by trypsinization and suspended at a concentration of 10 6 cells/mL in 2% FBS/PBS. Cells (5ϫ10 3 to 10 4 ) were analyzed by fluorescence-activated cell sorter (FACS, Becton Dickinson, research software version B 2/88) and an argon-ion laser (514-nm excitation) and a 580-nm filter. The data collected from the cells were analyzed with Consort 30 software.
Degradation Assay
For the degradation assay, LDL was iodinated with carrier-free Na 125 I, 23 acetylated with acetic anhydride, 32 and oxidized by overnight incubation with copper ions (20 mol/L). 23 Modified, iodinated LDL was used for the degradation analyses at 5 to 10 g/mL. A 25-fold excess of unlabeled acLDL or oxLDL was used in the competition assays. After the cells were washed, the amounts of 125 I-labeled, acid-soluble material in the medium (degradation) and in the cells (cell-associated activity) were determined. 23 Values obtained from cell-free wells were subtracted before calculating the results. Protein concentrations were determined by the method of Lowry et al. 34 
Lipid Staining
Cells (5ϫ10 3 to 10 4 ) were preincubated on chamber slides for 2 days in 10% lipid-deficient serum/DMEM. On the third day, the medium was removed and fresh medium with 100 to 360 g/mL acLDL was added. For competition analysis, a 5-fold excess of polyinosinic acid was used. After a 1-to 3-day incubation, the cells were washed with 1ϫ PBS, fixed with 1.25% glutaraldehyde, and stained with oil red O for 15 minutes, followed by hematoxylin counterstaining. Cells were then washed in tap water, and lipid staining was evaluated by light microscopy.
Apoptosis and Cell Death Assay
Annexin V (annexin V-FITC apoptosis detection kit, Genzyme) was used for identification of the cells undergoing an early phase of apoptosis. Annexin V binds to exposed phosphatidylserine in the outer leaflet of the plasma membrane due to disruption of phospholipid asymmetry characteristic of early apoptotic events. Because translocation of phosphatidylserine to the external cell surface also occurs during necrosis, annexin V-FITC was used in conjunction with the vital dye propidium iodide (PI) to distinguish apoptotic cells (annexinϩ/PIϪ) from necrotic cells (annexinϪ/PIϩ) or those cells that had already died due to apoptosis (annexinϩ/PIϩ). Uptake of the fluorescent dyes was measured from 10 4 cells by flow cytometry. The protocol was standardized by using etoposide (8 mol/L) and okadaic acid (5 nmol/L) treatments, which are known to cause apoptosis in cultured cells. 35, 36 
Results
Northern and Southern Blot Analyses
After gene transfer, 33 pLSRNL retrovirus producer clones were selected for further analysis. All of the isolated clones were positive for neomycin mRNA (Figure 2 ). Seventy-five percent of the clones were also positive for SR-A mRNA. Northern blot analysis of poly(A)ϩ mRNA showed one 5.5-kb band in the transduced pLSRNL cells with the bovine SR-A probe and 5.5-and 2-kb bands with the neomycin probe, corresponding to transcripts driven by the LTR (polycistronic mRNA) and the internal RSV promoter, respectively. Clones 11 and 23 expressed only the 2-kb internal neomycin transcript.
To document the integration of the SR-A cDNA into the genome of the transduced cells, Southern blot analysis of several clones was performed (data not shown). After digestion of the clones with BspTI, a 5-kb band was obtained in all but 2 clones, thus verifying integration of the complete retroviral cassette. Three smaller bands were present in the 2 aberrant clones. The reason for the additional bands in these clones remains unknown, but it may be due to rearrangements in the retroviral cassette during the integration step (data not shown). Thus, retroviral gene transfer does not always lead to a properly oriented functional expression cassette in the transduced cells.
Immunocytochemistry and Immunoelectron Microscopy
The presence of SR-A in the transduced cells was studied by immunocytochemistry. Protein was located in the cytoplasm and was concentrated in areas near the nucleus (Figure 3) . The presence of SR-A in the transduced mouse fibroblasts was studied by immunoelectron microscopy. A positive reaction for SR-A was detected in the transduced cells ( Figures 4A and 4B) . At higher magnification, the reaction for SR-A was observed on the plasma membrane condensed at coated-pit-like structures and in some intracellular structures similar to endocytotic vesicles ( Figure 4C ). These findings suggest, but do not prove, participation of the transduced SR-A in a functional endocytotic pathway. No positive reaction was observed in the untransduced control cells ( Figure 4D ).
Fluorescence Microscopy and Flow Cytometry Analysis of DiI-acLDL Uptake
As analyzed by fluorescence microscopy, transduced RAASMC clones efficiently internalized DiI-acLDL, whereas untransduced cells did not express any detectable SR-A activity ( Figure 5 ). In the transduced cells, DiI-acLDL was detected in spherical vesicles that were evenly distributed throughout the cytoplasm ( Figure 5 ).
Transduced fibroblasts and SMCs analyzed by flow cytometry showed functional SR-A receptors on the cell surface. No 
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uptake of DiI-acLDL was detected in the untransduced control cells ( Figure 6A ) unless they were stimulated. SMC clone 14 showed 60% to 80% higher DiI-acLDL uptake activity than the untransduced control SMCs, and the uptake was totally inhibited by a 40-fold excess of unlabeled acLDL or polyinosinic acid. Cytochalasin D was used to inhibit phagocytosis, but it had no effect on the uptake of DiI-acLDL by the transduced SMCs (data not shown). Flow cytometry analysis also revealed altered morphology of the SR-Atransduced SMCs compared with untransduced, control SMCs. The transduced cells were bigger and more granular than the control cells ( Figure 6B ). PMA (50 ng/mL) pretreatment for 24 hours increased the binding of DiI-acLDL in LacZ-transduced control cells, but only a small increase was seen in SR-A-transduced cells after PMA treatment ( Figure  6C) .
Degradation Assays
To demonstrate that the transduced SR-A was functional, degradation rates of 125 I-labeled acLDL were studied. Degradation activity was measured in 8 fibroblast clones and 2 SMC clones (Figure 7 ). Six fibroblast clones had SR-A in the right orientation (clones 5, 10, 14, 16, 21, and 23) and 2 clones (11 and 17) in the reverse orientation (derived from pLS r NL). Degradation of 125 I-acLDL in the best-transduced clones (5, 16, 21, and 14) having SR-A in the right orientation was 9-to 22-fold higher than in the control cells. The degradation activity of the untransduced control cells, SR-A clones 17, 11, and 23, and in LacZ-transduced cells was Ͻ10 ng/mg cell protein, whereas corresponding values for the best-transduced clones 5, 16, 21, and 14 were 216Ϯ59, 126Ϯ96, 114Ϯ44, and 86Ϯ11 ng/mg cell protein, respectively ( Figure 7A ). Displacement assays with a 25-fold excess of unlabeled acLDL showed a 42% decrease in the degradation of 125 I-acLDL in the most active clone 5. For comparison, the degradation of 125 I-acLDL in mouse peritoneal macrophages was Ϸ2.5 to 8 g/mg cell protein (data not shown). Two transduced SMC clones (clones 12 and 14) showed 6-to 8-fold increased degradation of 125 I-acLDL ( Figure 7B ). Degradation was effectively competed by unlabeled acLDL, oxLDL, and polyinosinic acid. In long-term cultures, the degradation rates of the transfected clones were somewhat lower but remained stable for at least 9 months (data not shown). Average degradation activities of the transduced clones were 487 ng/mg cell protein for clone 14 and 293 ng/mg cell protein for clone 12. A 25-fold excess of the unlabeled acLDL or polyinosinic acid decreased the degradation to 20% and 10% of the control values, respectively, whereas oxLDL decreased the degradation to 40% of the 
Lipid Staining
Clear differences were seen in lipid loading after oil red O staining in the transduced and untransduced fibroblasts and SMCs (Figure 8 ). Incubation with 100 g/mL acLDL led to foam cell formation in SR-A-transduced fibroblasts, whereas 360 g/mL acLDL was needed to cause foam cell formation in the SR-A-transduced SMCs. Some differences were observed in the distribution pattern of lipid vesicles in fibroblasts and SMCs after incubation with 100 g/mL acLDL. In fibroblasts, the lipid vesicles were mostly seen in perinuclear areas, whereas in SMCs the lipid vesicles were mostly located in the periphery of the cell (Figure 8 ).
Apoptosis and Cell Death
The effects of oxLDL on apoptosis and cell death were measured in SR-A-transduced SMCs and control cells by Figure 9A ). The proportion of late apoptotic (annexinϩ/PIϩ) cells was also moderately increased. Untreated control and transduced SMCs were primarily annexinϪ/PIϪ, indicating that they were viable and not undergoing enhanced apoptosis or cell death. Incubation with acLDL or native LDL did not induce any significant apoptosis (data not shown). A 48-hour incubation with a higher concentration of oxLDL (500 g/mL) increased annexin V positivity in the SR-Atransduced SMCs by 3.6-fold compared with the control cells ( Figure 9B ). In the transduced SMCs, a 4.3-fold increase in PIϩ but annexinϪ cells (ie, necrotic cell death) and a 2.9-fold increase in the control cells were seen when compared with untreated control cells, indicating that the higher concentration of oxLDL also induced cell death without apoptosis.
Discussion
Retrovirus techniques were used to generate cell lines that express SR-A activity. 37 Advantages of retroviral gene transfer include stability of the cell lines over long periods of time; a several-fold increase in the transgene activity that can be achieved under the viral LTR promoter; and inclusion of a selection marker in the expression cassette, which permits isolation and maintenance of homogeneous clones of the transduced cells. Thus, these stable cell lines offer several advantages over conventional transient transfections wherein significant variation exists in transfection efficiency and duration of the transgene activity. Possible limitations of the retroviral techniques include unpredictable alterations in target cell functions due to random integration of the transgene and the inability to regulate transgene function by endogenous regulators. 37 The role of SR-A in the development of macrophage-derived foam cells is well established. In human, rabbit, and mouse arteries, SR-A receptors are expressed in lesion macrophages. 6 -10 Because oxLDL is present in atherosclerotic lesions, 23, 38 it is conceivable that SR-A could lead to lipid accumulation and foam cell formation. The role of SR-A in atherogenesis has been confirmed in SR-A gene-disrupted mice, which develop 60% less atherosclerosis when bred with apoE-knockout mice compared with control mice. 11 Also, marked variability in the induction of SR-A activity has been reported in 2 strains of rabbit that differ in their susceptibility to atherosclerosis. 39 Inconsistent data exist regarding the role of SR-A in nonmacrophage cell lines. Immunohistochemical studies suggest that SR-A is expressed in some SMCs in the ballooninjured, hypercholesterolemic rabbit neointima, 14, 40 whereas in other studies, SR-A mRNA or immunoreactive protein has not been identified in human, rabbit, or mouse lesion SMCs. 6,8 -10 However, in vitro rabbit and human SMCs express SR-A after PMA stimulation. Endothelial cells are known to take up acLDL, and SR-A immunoreactivity has been detected in the endothelium with the use of anti-peptide antibodies, 41 whereas no such reactivity has been found in other studies. 6,8 -10,40 It is possible that conflicting results are at least partly due to differences in the specificity of reagents used for the studies.
We have demonstrated that functional SR-A activity can be stably expressed in SMC and fibroblast cell lines. Transfection leads to foam cell formation with both acLDL and oxLDL. Even though human atherosclerotic lesions contain a significant portion of SMC-derived foam cells, it has been difficult to generate SMC foam cells in vitro. 32, 42 Accordingly, the consequences of foam cell formation to SMC biology have been difficult to study. Stably transfected cell lines can be used as models of foam cell formation and lipid accumulation in vitro. The capacity of transfected SMCs to take up acLDL or oxLDL was much lower than that of macrophages, which suggests that SMC-derived foam cells might not develop as rapidly as macrophage-derived foam cells. However, human lesions develop slowly during the first 3 decades of life, 43, 44 and it is conceivable that even a low SR-A activity could lead to a gradual oxLDL accumulation in arterial SMCs over several years. Increased oxLDL accumulation without foam cell formation may also alter SMC functions through various effects of oxidized lipids on transcription factors and gene expression. [45] [46] [47] [48] Other lipoprotein receptors than SR-A and uptake mechanisms may also contribute to lipid uptake in lesion SMCs. 4 It was found that after incubation with oxLDL, the stably transduced SMC lines were more susceptible to apoptosis and cell death, which together with foam cell formation could contribute to atheroma formation and lesion development. These findings are in line with recent reports that oxLDL can cause apoptosis in cultured cells and that apoptotic cell death occurs in human and experimental atherosclerotic plaques. [45] [46] [47] 49, 50 Susceptibility to apoptosis in response to oxLDL incubation was increased in the SR-A-transduced cells, from 1.5-to 2.6-fold, in comparison with the untransduced cells, which is in line with a 2-fold increase in the degradation of 125 I-oxLDL seen in the transduced cells. OxLDL caused more apoptosis compared with acLDL, despite the fact that an 8-fold increase in the rate of 125 I-acLDL degradation was seen in the transduced SMCs. However, it is impossible to fully distinguish the degree of apoptosis caused by the SR-A-mediated uptake of oxLDL from that of the non-SR-A-mediated uptake. The results also suggest that the role of SR-A in cell death is indirect and due to an increased uptake of oxLDL. It is important to note that the increased rate of apoptosis was not associated with an increased rate of replication (P.L. et al, unpublished observations, 1998). 51 Even though apoptosis has been shown to occur in plaques and not in fatty streaks, SMCs within human fatty streaks express Bax, a proapoptotic protein of the Bcl-2 family 52 that increases the susceptibility of cells to apoptosis. 53 The expression of Bax can activate a common pathway of apoptosis by triggering a mitochondrial cytochrome c release. 54 It has also been shown that apoptosis in vascular SMCs can be induced through caspase-3 activation and Bcl-2 downregulation by lipid peroxides, which are present in oxLDL, 55 and that oxidative stress response elements are present in the SR-A promoter of human SMCs. 56 In conclusion, our results show that SR-A expression in SMCs and fibroblasts leads to proatherogenic changes by increasing lipid accumulation and predisposing cells to apoptosis. In addition to the significant role of SR-A in macrophages, these receptors may participate in atherogenesis by predisposing nonmacrophage cells to proatherogenic changes. It is possible that modulation of SR-A activity may be useful for the prevention of proatherogenic changes in vivo.
